In contrast, entorhinal RI declined with age among APOE4 non-carriers, which may reflect aging-related neuronal loss or dystrophy among those with reduced genetic risk for AD, consistent with age-related entorhinal atrophy observed in the general population [41]. This evidence concerns the gene APOE and Alzheimer disease.